Strides Pharma Q1 net loss at Rs 4 crore
New Delhi: Strides Pharma Science reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30.
The company had posted a net profit of Rs 5.78 crore in April-June 2017, Strides Pharma said in a BSE filing.
Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review. It was Rs 657.78 crore for the same period a year ago.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd